Advancing Lung Cancer Care in the U.S.
As a National Cancer Institute-designated Comprehensive Cancer Center, we helped pioneer minimally invasive surgery techniques. We are also part of the National Comprehensive Cancer Network, an alliance of the nation’s leading cancer centers dedicated to improving patient care.
Decades of Duke Research Inform Your Treatment
Our doctors use a large tissue bank and database of patients treated for lung cancer at Duke since 1995. We study why some lung cancer patients respond to treatments better than others in order to reduce your symptoms and treat your cancer. Our medical oncologists have developed several drugs that have received FDA approval. These drugs help improve patient outcomes.
When Lung Cancer Spreads to Brain or Spine
New treatments are making it possible for people to live longer, with a better quality of life, when cancer has spread to the brain or spine. Duke experts in the medical and surgical management of metastatic brain and spine tumors use these advanced therapies to extend life for people who may have been told they are out of options.
Access to Clinical Trials
Every day, our researchers are conducting approved clinical trials to develop new treatment options and give more insights into curing lung cancer and improving our patients’ quality of life. You may be eligible to participate in our clinical trials, which help advance treatment guidelines and enhance your care.